Voloridge Investment Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,494
Closed -$897K 1381
2023
Q3
$897K Sell
5,494
-4,102
-43% -$968K ﹤0.01% 1119
2023
Q2
$3.15M Sell
9,596
-6,112
-39% -$1.86M 0.01% 835
2023
Q1
$4.34M Buy
15,708
+7,157
+84% +$2.63M 0.02% 715
2022
Q4
$3.31M Buy
8,551
+616
+8% +$174K 0.02% 809
2022
Q3
$1.9M Buy
+7,935
New +$2.12M 0.01% 998
2021
Q4
Sell
-5,207
Closed -$3.86M 1766
2021
Q3
$3.86M Buy
5,207
+365
+8% +$249K 0.02% 789
2021
Q2
$3.63M Buy
4,842
+1,985
+69% +$1.52M 0.03% 754
2021
Q1
$2.33M Buy
+2,857
New +$2.2M 0.02% 769

Other funds holding OM

Voloridge Investment Management's OM Position: Q4 2023 in Review

Voloridge Investment Management sold out of Outset Medical (OM) in Q4 2023, closing a stake of 5,494 shares — an estimated $897K sold.

Voloridge Investment Management first reported a position in OM in Q1 2021 and held it in 8 quarters. The position peaked at $4.34M in Q1 2023. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Voloridge Investment Management reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 5,494 Outset Medical shares in Q4 2023, an estimated $897K.
  • Voloridge Investment Management first reported a position in Outset Medical in Q1 2021 and held it in 8 quarters.
  • Voloridge Investment Management's Outset Medical position peaked at $4.34M in Q1 2023.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Voloridge Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.